ResMed | RMD - Loan Capital



ResMed reported $658.39M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Ansell USD 706.6M 319.8M Jun/2024
AtriCure USD 61.86M 0 Jun/2025
Baxter International USD 9.41B 962M Mar/2025
Cochlear AUD 203.5M 1.4M Dec/2024
Cooper Companies USD 2.43B 96.1M Jul/2025
CSL USD 9.33B 1.91B Dec/2024
Dexcom USD 1.24B 56.7M Jun/2025
Edwards Lifesciences USD 597.8M 100K Mar/2025
Fisher Paykel Healthcare NZD 66.9M 3.2M Mar/2025
Globus Medical USD 173K 84K Jun/2025
Haemonetics USD 920.83M 397K Jun/2025
Hologic USD 2.51B 37.5M Jun/2025
Idexx Laboratories USD 449.81M 13K Jun/2025
Insulet USD 939M 673.3M Jun/2025
Integra LifeSciences USD 1.23B 3.7M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 598.7M 37.3M Jun/2025
Medtronic USD 25.64B 1.66B Apr/2025
Philips EUR 7.18B 126M Jun/2025
Ramsay Health Care AUD 10.69B 359.3M Dec/2024
ResMed USD 658.39M 4.73M Jun/2025
Sigma Healthcare AUD 124.31M 2.53M Jul/2024
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Steris USD 1.9B 15.6M Jun/2025
Teleflex USD 1.8B 5.68M Jun/2025
Thermo Fisher Scientific USD 33.02B 1.64B Jun/2025